Announcements Trials
Browse Landscape

Phase

Phase NA 142Phase 1 126Phase 2 117Phase 1/2 62Phase 3 32Phase EARLY_PHASE1 10Phase 2/3 6Phase 4 4

Status

Recruiting 2Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Genitourinary 1

Conditions

Breast Neoplasms 24Neoplasms 11Carcinoma, Non-Small-Cell Lung 9Prostatic Neoplasms 8Multiple Myeloma 8Lung Neoplasms 6Melanoma 5Leukemia, Myeloid, Acute 5Neoplasm Metastasis 4Glioma 4Colorectal Neoplasms 4Carcinoma, Hepatocellular 4Tuberous Sclerosis 3Stomach Neoplasms 3Sarcoma 3Papillomavirus Infections 3Leiomyoma 3Hematologic Neoplasms 3Glioblastoma 3Carcinoma, Renal Cell 3Polycythemia Vera 2Pain 2Oligodendroglioma 2Neoplasms by Site 2Myasthenia Gravis 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Heart Failure 2Febrile Neutropenia 2Endometrial Neoplasms 2Bronchiolitis Obliterans Syndrome 2

Interventions

zidovudine 5'-monophosphate-mannose-albumin conjugate 1galactosamine-conjugated serum albumin-conjugated-(rhodamine X)20 1gadolinium ethoxybenzyl DTPA 1gadobenic acid 1Sodium Chloride 1Ropivacaine 1Ringer's acetate 1HMPL-013 1Albumins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Colorectal Neoplasms × 90 days × Clear all
NCT07624916 2026-06-03

Transversus Abdominis Plane and Rectus Sheath Block for Robotic Colectomy

Tri-Service General Hospital

Phase 4 Not yet recruiting
90 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06562543 2026-05-20

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

Takeda

Phase 4 Recruiting
78 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05726136 2026-04-30

FC-VE

University Hospital, Linkoeping

Phase 4 Recruiting
60 enrolled
GastrointestinalGenitourinary

Neoplasms, Urologic Neoplasms, Colorectal Neoplasms

NCT04973007 2026-04-22

Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases

University of Colorado, Denver

Phase 4 Terminated
10 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡